Profile
Mr. Steven Tuch is a Managing Director & Co-Head of Healthcare Equity Capital Markets at Mizuho Securities USA LLC.
Mr. Tuch was previously employed as a Chief Financial Officer & Executive Vice President by vTv Therapeutics, Inc. and a Head-Corporate Development by Rallybio Corp.
He received his undergraduate degree from the University of Michigan and an MBA from Stanford Graduate School of Business.
Steven Tuch active positions
| Companies | Position | Start |
|---|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Director of Research - Equity | 01/03/2025 |
Former positions of Steven Tuch
| Companies | Position | End |
|---|---|---|
| VTV THERAPEUTICS INC. | Director of Finance/CFO | 21/03/2025 |
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01/01/2022 |
Training of Steven Tuch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Mizuho Securities USA LLC
Mizuho Securities USA LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
- Stock Market
- Insiders
- Steven Tuch
















